59115-90-1

Basic information

• Product Name: (1-Phenylcyclopentyl)methanol
• Synonyms: (1-Phenylcyclopentyl)methanol
• CAS NO: 59115-90-1
• Molecular Formula: C₁₂H₁₆O
• Molecular Weight: 176.26
• Mol File: 59115-90-1.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 286.8°Cat760mmHg
• Flash Point: 123.6°C
• Appearance: /
• Density: 1.037g/cm³
• Vapor Pressure: 0.0012mmHg at 25°C
• Refractive Index: 1.544
• PKA: 15.05±0.10(Predicted)
• CAS DataBase Reference: (1-Phenylcyclopentyl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (1-Phenylcyclopentyl)methanol(59115-90-1)
• EPA Substance Registry System: (1-Phenylcyclopentyl)methanol(59115-90-1)

Safety Data

• Hazardous Substances Data: 59115-90-1(Hazardous Substances Data)

Usage

Description

(1-Phenylcyclopentyl)methanol is a chemical compound with the molecular formula C13H16O. It is an organic compound that contains a cyclopentyl ring and a phenyl group attached to a methanol molecule. (1-Phenylcyclopentyl)methanol is known for its unique structural properties and is considered to be a potential chiral ligand.

Uses

Used in Organic Synthesis:
(1-Phenylcyclopentyl)methanol is used as a building block for the production of other chemical compounds, playing a crucial role in organic synthesis.
Used in Pharmaceutical Production:
It may also be used as a precursor in the synthesis of pharmaceuticals and other fine chemicals, contributing to the development of new drugs.
Used in Asymmetric Synthesis:
(1-Phenylcyclopentyl)methanol is considered to be a potential chiral ligand and can be used in asymmetric synthesis, which is important for creating enantiomerically pure compounds.
Used in Medicinal Chemistry and Drug Discovery:
Additionally, it may have potential applications in the field of medicinal chemistry and drug discovery due to its unique structural properties, which can be leveraged to design and develop novel therapeutic agents.

InChI:InChI=1/C12H16O/c13-10-12(8-4-5-9-12)11-6-2-1-3-7-11/h1-3,6-7,13H,4-5,8-10H2

Upstream product

• 17380-62-0 1-phenylcyclopentanecarboxylic acid chloride 
• 4535-95-9 1-ethoxycarbonyl-1-phenylcyclopentane 
• 4535-96-0 1-phenyl-1-cyclopentanecarboxylic acid methyl ester 
• 77-55-4 1-phenyl-1-cyclopentanecarboxylic acid 
• 101-97-3 Ethyl 2-phenylethanoate 
• 77-57-6 1-phenyl-1-cyclopentanecarbonitrile 
• 140-29-4 phenylacetonitrile 
• 21573-69-3 1-phenyl-1-cyclopentanecarboxaldehyde 

Downstream Products

• 92040-71-6 carbamic acid-(1-phenyl-cyclopentylmethyl ester) 
• 102899-10-5 tetra-N-ethyl-2-(1-phenyl-cyclopentylmethoxy)-propanediyldiamine 
• 21573-69-3 1-phenyl-1-cyclopentanecarboxaldehyde 
• 136089-15-1 O-<2-<2-(diethylamino)ethoxy>ethyl>-1-phenyl-1-cyclopentanemethanol 
• 85002-68-2 1-Nitro-4-(1-phenyl-cyclopentylmethoxy)-benzene 
• 95424-44-5 (1-Phenylcyclopentyl)carbinyl tosylate 
• 85003-26-5 2-Chloro-3-[4-(1-phenyl-cyclopentylmethoxy)-phenyl]-propionic acid ethyl ester 
• 74779-49-0 5-[4-(1-Phenyl-cyclopentylmethoxy)-benzyl]-thiazolidine-2,4-dione 
• 88346-29-6 1-phenylisochroman-4-spiro-1'-cyclopentane 
• 88346-34-3 1-(2-benzoylphenyl)cyclopentanecarboxylic acid 
• 88346-41-2 1-phenyl-3,5-dihydro-4H-2,3-benzodiazepin-4-one-5-spiro-1'-cyclopentane 
• 88346-43-4 1-hydrazino-1-phenyl-4-spiro-1'-cyclopentaneisochroman-3-one 
• 5407-84-1 β-phenyl-β,β-tetramethylenepropionitrile 
• 1616922-13-4 2-cyclopropyl-9-hydroxy-6-(1-phenylcyclopentylmethyl)-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,8-dione 

Relevant articles and documents

Preparation of isoquinazolines: Via metal-free [4 + 2] cycloaddition of ynamides with nitriles

TfOH-mediated [4 + 2] cycloaddition of ynamides with nitriles to construct 1,2-dihydroquinazolines is realized by a direct reaction in moderate to excellent yields (up to 93%) in a stereospecific manner. A rapid and efficient strategy has been employed for the syntheses of alkyl-substituted 1,2-dihydroquinazoline derivatives, and it exhibits good functional group tolerance, has a short reaction time, shows excellent diastereoselectivity, and is a simple and high-yielding reaction.

Protected amino hydroxy adamantane carboxylic acid and process for its preparation

Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided. The provided compounds can be used for treating diabetes and related diseases, especially Type II diabetes, and other diseases as set out herein, employing such DP 4 inhibitor or a combination of such DP 4 inhibitor and one or more of another antidiabetic agent such as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulin and/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or other therapeutic agent.

PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

The present invention relates to a compound having the general formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.